Cocoa

'''Cocoa''' is a [[substance_class:psychoactive/stimulant]] preparation derived from the seeds of '''''Theobroma cacao''''' L. (Malvaceae), a tropical evergreen tree native to the Amazon and Orinoco river basins. Its psychoactive profile is dominated by [[substance:theobromine]], a methylxanthine present at approximately ten times the concentration of [[substance:caffeine]], with secondary contributions from flavan-3-ol polyphenols{{cite|doi=10.1111/1750-3841.70979|anchor=91518b26}}. Principal preparations include cocoa powder beverages, dark chocolate, and standardized flavanol extracts, with stimulant effects lasting 2–6 hours. Archaeological evidence of human cacao use dates to approximately 600 BCE in Mesoamerica, where Maya and Aztec civilizations consumed it as a ceremonial and dietary beverage{{cite|pubmed=12124611|anchor=99d8690c}}. Linnaeus formally described the species in 1753, naming the genus ''Theobroma'' ("food of the gods"). Modern clinical interest centers on cocoa flavanols, with large-scale randomized trials — COSMOS (cardiovascular endpoints) and COSMOS-Mind (cognitive outcomes) — investigating standardized daily doses of 500 mg flavanols{{cite|doi=10.1002/alz.12767|anchor=55ffe897}}. Cocoa and its products are regulated exclusively as food commodities in all major jurisdictions; no constituent alkaloid is scheduled under [[glossary:drug-control|international drug control]] conventions. Theobromine exerts its primary central and peripheral effects through [[glossary:antagonism]] of [[glossary:adenosine]] A₁ and A₂A [[glossary:receptor|receptors]] and [[glossary:inhibition]] of phosphodiesterases, increasing intracellular cAMP{{cite|doi=10.3390/ijms231810510|anchor=7361ae30}}. Caffeine shares these targets at lower concentrations. The flavan-3-ol fraction — principally epicatechin — stimulates endothelial nitric oxide synthase, producing vasodilation through a mechanistically distinct pathway{{cite|doi=10.1016/j.vph.2015.05.011|anchor=c628363f}}. Theobromine's oral bioaccessibility exceeds 85%, with an [[glossary:half-life]] of approximately 6–10 hours. At typical dietary doses, cocoa produces mild [[effect:stimulation]], [[effect:wakefulness]], and subtle mood [[glossary:elevation]] consistent with low-grade adenosine receptor [[glossary:blockade]]. The [[glossary:subjective-experience]] is markedly attenuated compared to caffeine-dominant preparations such as coffee, reflecting theobromine's weaker [[glossary:brain-penetration|CNS penetration]] and lower reinforcing potential{{cite|doi=10.3389/fphar.2015.00030|anchor=3912705d}}. Effects and duration vary substantially by preparation method; dark chocolate delivers higher methylxanthine loads than cocoa powder beverages. The primary safety concerns for cocoa are cadmium and lead [[glossary:contamination]] in commercially produced dark chocolate — particularly from Latin American cacao-growing regions{{cite|doi=10.1021/acs.jafc.9b08295|anchor=8532f54a}} — and caffeine-related [[glossary:adverse-effects]] at high intake. Caffeine [[glossary:dependence]], characterized by [[glossary:withdrawal]] [[effect:headache]], [[glossary:fatigue]], and [[effect:irritability]] resolving within 5–7 days, can develop with heavy daily dark chocolate consumption, though the caffeine load per serving is below that of coffee. No dependence syndrome specific to theobromine has been documented. Whether high-dose "ceremonial cacao" preparations produce pharmacologically distinct effects beyond standard dietary consumption remains clinically uncharacterized.

'''Cocoa''' (''Theobroma cacao'' L., Malvaceae) is a tropical evergreen tree whose seeds are processed into chocolate, cocoa powder, and flavanol extracts — all of which function as mild [[substance_class:psychoactive/stimulant|stimulants]]. Its dominant psychoactive constituent, [[substance:theobromine]], is present at roughly ten times the concentration of [[substance:caffeine]] in cacao seeds{{cite|doi=10.1111/1750-3841.70979|anchor=6cf9a584}}. Theobromine works by blocking [[glossary:adenosine]] [[glossary:receptor|receptors]] in the brain, reducing the [[glossary:fatigue]] signal and producing gentle [[effect:wakefulness]] and light cardiovascular [[effect:stimulation]]{{cite|doi=10.3390/ijms231810510|anchor=e8ab9695}}. Human cacao use dates to approximately 600 BCE in Mesoamerica, where Maya and Aztec civilizations consumed it as a ceremonial and dietary beverage{{cite|pubmed=12124611|anchor=de2988d5}}. Spanish explorers brought it to Europe in the 1520s, and colonial demand transformed it into one of the world's most widely traded commodities. Today cocoa is a global food staple, and ongoing clinical trials are testing cocoa flavanols for cardiovascular and cognitive benefits{{cite|doi=10.1002/alz.12767|anchor=049b2792}}. [[index:effects|Subjective effects]] include gentle wakefulness, mild mood [[glossary:elevation]], diffuse physical [[glossary:warmth]], and a slight focus boost. The experience is markedly gentler than coffee — closer to a mild green tea — reflecting theobromine's weaker [[glossary:brain-penetration]]{{cite|doi=10.3389/fphar.2015.00030|anchor=2ccbd7ac}}. At higher intakes, especially from dark chocolate, caffeine becomes the dominant unsought effect: [[effect:insomnia]], [[effect:restlessness]], and [[effect:anxiety]]. Caffeine [[glossary:dependence]] can develop with heavy daily dark chocolate consumption; no dependence syndrome specific to theobromine has been documented{{cite|doi=10.3389/fphar.2015.00030|anchor=a437e9be}}. The most distinctive risk is cadmium and lead [[glossary:contamination]] in commercial dark chocolate from Latin American growing regions — a concern rarely visible on product labels{{cite|doi=10.1021/acs.jafc.9b08295|anchor=ea850690}}. The pharmacology of high-dose ceremonial cacao remains clinically uncharacterized, and most safety data covers only standard dietary consumption.

'''Cocoa''' (''Theobroma cacao'' L., Malvaceae) is a tropical evergreen tree whose seed-derived preparations — chocolate, cocoa powder, and flavanol extracts — function as mild [[substance_class:psychoactive/stimulant|stimulants]]. Its dominant psychoactive constituent, [[substance:theobromine]], is a methylxanthine present at roughly ten times the concentration of [[substance:caffeine]]{{cite|doi=10.1111/1750-3841.70979|anchor=8f247b5d}}. Theobromine produces its principal effects by blocking [[glossary:adenosine]] A₁ and A₂A [[glossary:receptor|receptors]] and inhibiting phosphodiesterases, raising intracellular cAMP to promote [[effect:wakefulness]] and gentle cardiovascular [[effect:stimulation]]{{cite|doi=10.3390/ijms231810510|anchor=68074300}}. Human cacao use dates to approximately 600 BCE in Mesoamerica, where Maya and Aztec civilizations consumed it as a ceremonial and dietary beverage{{cite|pubmed=12124611|anchor=56975f3f}}. European contact in the 1520s transformed cacao into a global commodity, and modern clinical interest now centers on cocoa flavanols, with large-scale trials such as COSMOS investigating standardized daily doses of 500 mg flavanols for cardiovascular and cognitive endpoints{{cite|doi=10.1002/alz.12767|anchor=d4cf1a44}}. Cocoa and all its products are regulated exclusively as food commodities; no constituent alkaloid is internationally scheduled. [[index:effects|Subjective effects]] include mild stimulation, sustained wakefulness, subtle mood [[glossary:elevation]], and a diffuse sense of physical [[glossary:warmth]]. The overall experience is markedly gentler than coffee — closer to a mild green tea — reflecting theobromine's weaker [[glossary:brain-penetration|CNS penetration]] and lower reinforcing potential{{cite|doi=10.3389/fphar.2015.00030|anchor=13f98e83}}. At higher intakes, caffeine-mediated [[effect:insomnia]], [[effect:restlessness]], and [[effect:anxiety]] become the primary unsought effects. Caffeine [[glossary:dependence]] can develop with heavy daily dark chocolate consumption, though per-serving caffeine loads remain below those of coffee; no theobromine-specific dependence syndrome has been documented{{cite|doi=10.3389/fphar.2015.00030|anchor=556eb57d}}. The most distinctive safety concern is cadmium and lead [[glossary:contamination]] in commercially produced dark chocolate, particularly from Latin American cacao-growing regions{{cite|doi=10.1021/acs.jafc.9b08295|anchor=20035754}}. The pharmacology of high-dose "ceremonial cacao" preparations remains clinically uncharacterized.

===Traditional and historical use=== The earliest confirmed chemical evidence of cacao consumption comes from ceramic vessels at the Maya site of Colha in Belize, dated to approximately 600 BCE — extending the archaeological record by roughly 1,000 years beyond previous estimates{{cite|pubmed=12124611|anchor=203bb668}}. Molecular evidence places ''Theobroma cacao'' domestication at roughly 5,450–5,300 years ago in the Upper Amazon basin{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=51a1855b}}. The Olmec, Maya, and Aztec civilizations prepared cacao as an unsweetened frothy beverage — ''xocolatl'' in Nahuatl — used in dietary and ceremonial contexts; cacao beans also served as currency in Aztec trade. ===Western discovery and global spread=== Spanish explorers introduced cacao to Europe in the 1520s{{cite|url=https://en.wikipedia.org/wiki/Theobroma_cacao|anchor=fae68c63}}, and by the mid-17th century chocolate houses had become fashionable social gathering places across European capitals. Colonial demand drove plantation cultivation across the Caribbean and Latin America. Successive disease outbreaks progressively shifted production to West Africa, which now dominates global supply{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=ffebd053}}. ===Modern era=== Carolus Linnaeus formally named the species ''Theobroma cacao'' in ''Species Plantarum'' (1753) — ''Theobroma'' means "food of the gods" in Greek{{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=6fa952a0}}. [[substance:theobromine]] was first isolated from cacao beans in 1841{{flag|citation-needed}}. Modern clinical interest accelerated in the 1990s after cardiovascular health observations in the Kuna people of Panama{{cite|doi=10.1016/j.vph.2015.05.011|anchor=71f4a23f}}, culminating in the COSMOS and COSMOS-Mind trials testing 500 mg/day of standardized cocoa flavanols for cardiovascular and cognitive endpoints{{cite|doi=10.1093/ajcn/nqac055|anchor=654a27d1}}{{cite|doi=10.1002/alz.12767|anchor=46cf4f21}}. {{DiscoverMore|Culture and lore}} The word "chocolate" derives from the Nahuatl ''xocolatl'', likely meaning "bitter water." Linnaeus's genus name ''Theobroma'' — "food of the gods" — reflects the reverence attached to cacao in Mesoamerican cosmology. European chocolate houses of the 17th and 18th centuries functioned as social and political gathering places comparable to coffeehouses, and cacao's transformation from an elite ceremonial drink to a mass-produced confection is one of the defining commodity stories of the colonial era. {{/DiscoverMore}}

===Discovery and early record=== Molecular analyses place the center of origin for ''Theobroma cacao'' in the Upper Amazon basin, with initial domestication dated to approximately 5,450–5,300 BP{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=54645bf4}}. The earliest chemical evidence of human cacao use — identified through HPLC-APCI-MS [[glossary:detection]] of [[substance:theobromine]] residues in spouted ceramic vessels — comes from the Maya site of Colha in northern Belize, dating to approximately 600 BCE{{cite|pubmed=12124611|anchor=09385d4f}}. This finding extended the confirmed archaeological record of cacao consumption by approximately 1,000 years from previous estimates. ===Traditional use=== Cacao cultivation reached Mesoamerica between 3,800 and 3,000 BP{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=022a5acd}}. The Olmec, Maya, and Aztec civilizations prepared cacao as an unsweetened, frothy beverage — referred to as ''xocolatl'' in Nahuatl — consumed in both dietary and ceremonial contexts. Cacao beans served simultaneously as currency in Aztec society. Classic Maya cylinder vessels bearing hieroglyphic inscriptions have been interpreted as cacao-drinking vessels, supported by chemical residue analysis, though specific vessel function attributions remain debated in the archaeological literature{{flag|citation-needed}}. ===European introduction and global cultivation=== Spanish explorers introduced cacao to Europe in the 1520s following contact with Mesoamerican civilizations{{cite|url=https://en.wikipedia.org/wiki/Theobroma_cacao|anchor=92f5625e}}. By the mid-17th century, chocolate houses had been established across European capitals among the elite. Colonial-era demand drove plantation cultivation in Trinidad, Venezuela, Ecuador, and the Caribbean. The collapse of the Trinidadian cacao industry in the 1720s due to "blast" disease, followed by the introduction of witches' broom (''Moniliophthora perniciosa'') to Bahia, Brazil in the late 1980s, progressively shifted global production to West Africa — now the dominant producing region{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=a7c5fdc9}}. ===Scientific description and modern research=== Carolus Linnaeus formally described and named ''Theobroma cacao'' in ''Species Plantarum'' (1753), assigning the genus name ''Theobroma'' (Greek: "food of the gods"){{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=1251c6b8}}. Theobromine was first isolated from cacao beans in 1841{{flag|citation-needed}}. Modern clinical interest in cocoa's bioactive constituents accelerated in the 1990s, prompted by cardiovascular health observations in the Kuna Indian population of Panama{{cite|doi=10.1016/j.vph.2015.05.011|anchor=7a6db742}}. Large-scale randomized clinical trials — including COSMOS (cardiovascular endpoints) and COSMOS-Mind (cognitive outcomes) — were initiated in the 2010s, testing standardized cocoa flavanol supplementation at 500 mg/day{{cite|doi=10.1093/ajcn/nqac055|anchor=c6f36971}}{{cite|doi=10.1002/alz.12767|anchor=16fb254c}}.

===Traditional and historical use=== Molecular analyses place the center of origin for ''Theobroma cacao'' in the Upper Amazon basin, with initial domestication dated to approximately 5,450–5,300 BP{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=88338630}}. The earliest confirmed chemical evidence of human cacao use comes from spouted ceramic vessels at the Maya site of Colha in Belize, dated to approximately 600 BCE — extending the archaeological record by roughly 1,000 years beyond previous estimates{{cite|pubmed=12124611|anchor=50bd894c}}. Cacao cultivation reached Mesoamerica between 3,800 and 3,000 BP{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=233d83c3}}. The Olmec, Maya, and Aztec civilizations prepared cacao as an unsweetened, frothy beverage — ''xocolatl'' in Nahuatl — consumed in both dietary and ceremonial contexts. Cacao beans simultaneously served as currency in Aztec society. Classic Maya cylinder vessels bearing hieroglyphic inscriptions have been interpreted as cacao-drinking vessels, though specific vessel function attributions remain debated{{flag|citation-needed}}. ===Western discovery and global spread=== Spanish explorers introduced cacao to Europe in the 1520s following Mesoamerican contact{{cite|url=https://en.wikipedia.org/wiki/Theobroma_cacao|anchor=e7bef063}}. By the mid-17th century, chocolate houses had become fashionable establishments across European capitals. Colonial demand drove plantation cultivation in Trinidad, Venezuela, Ecuador, and the Caribbean. Successive disease outbreaks — "blast" in 1720s Trinidad and witches' broom (''Moniliophthora perniciosa'') in late-1980s Bahia, Brazil — progressively shifted global production to West Africa, now the dominant cacao-producing region{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=dbd4fc78}}. ===Modern era=== Carolus Linnaeus formally described ''Theobroma cacao'' in ''Species Plantarum'' (1753), assigning the genus name ''Theobroma'' — Greek for "food of the gods"{{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=f51e37df}}. [[substance:theobromine]] was first isolated from cacao beans in 1841{{flag|citation-needed}}. Modern clinical interest accelerated in the 1990s, prompted by cardiovascular health observations in the Kuna Indian population of Panama{{cite|doi=10.1016/j.vph.2015.05.011|anchor=21be4334}}. Large-scale randomized trials — COSMOS (cardiovascular endpoints) and COSMOS-Mind (cognitive outcomes) — were launched in the 2010s, testing standardized cocoa flavanol supplementation at 500 mg/day{{cite|doi=10.1093/ajcn/nqac055|anchor=31609ebd}}{{cite|doi=10.1002/alz.12767|anchor=afb3b297}}. {{DiscoverMore|Culture and lore}} The word "chocolate" derives from the Nahuatl ''xocolatl'', likely meaning "bitter water." Linnaeus's genus name ''Theobroma'' — "food of the gods" — reflects the reverence attached to cacao in Mesoamerican cosmology. European chocolate houses of the 17th and 18th centuries functioned as social and political gathering places comparable to coffeehouses, and cacao's transformation from an elite ceremonial drink to a mass-produced confection is one of the defining commodity stories of the colonial era. {{/DiscoverMore}}

''Theobroma cacao'' L. belongs to the family Malvaceae (historically classified in Sterculiaceae before molecular revision). Three broad genetic groups are recognized in cultivation: Criollo, Forastero, and Trinitario — a Criollo × Forastero hybrid. Criollo beans are considered the highest quality but represent a small fraction of global production; Forastero dominates commercial agriculture. These groupings influence flavor, fermentation character, and — to a lesser extent — alkaloid concentration. The species is native to the tropical lowland forests of the Upper Amazon and Orinoco river basins{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=cc54fae0}}. It requires humid, shaded conditions within approximately 20° of the equator and is cultivated commercially across West Africa (Côte d'Ivoire, Ghana — now the world's largest producers), Southeast Asia, and Latin America. Wild populations persist in Amazonian forests, though commercial production relies entirely on cultivated stock. ''T. cacao'' is a small to medium evergreen tree (4–8 m under cultivation, up to 15 m in forest canopy). Leaves are simple, alternate, and glossy, measuring 15–30 cm. The species is cauliflorous — small, pale flowers emerge directly from the trunk and major branches rather than from new growth. Pollination is performed by midges (Ceratopogonidae). The fruit ("pod") is an ovoid berry 15–30 cm long, maturing through yellow, orange, or red coloration depending on variety. Each pod contains 20–60 seeds ("beans") embedded in a sweet, mucilaginous pulp. Harvesting involves manual cutting of ripe pods from the trunk. Beans are extracted, fermented for 5–7 days (a step critical to flavor development and alkaloid [[glossary:modification]]), sun-dried, and then roasted. The fermentation and roasting stages alter the phenolic and methylxanthine profile of the final product; unroasted "raw cacao" retains higher flavanol concentrations but also higher astringency.

''Theobroma cacao'' L. belongs to the family Malvaceae. Three broad genetic groups are recognized in cultivation: Criollo (high quality, limited production), Forastero (dominant in commercial agriculture), and Trinitario (a Criollo × Forastero hybrid). These groupings influence flavor, fermentation character, and alkaloid concentration. The species is native to the tropical lowland forests of the Upper Amazon and Orinoco river basins{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=8943eb0e}}. It requires humid, shaded conditions within roughly 20° of the equator. Côte d'Ivoire and Ghana now lead global commercial production; wild populations persist in Amazonian forests. ''T. cacao'' is a small to medium evergreen tree — typically 4–8 m under cultivation, up to 15 m in the forest canopy. Its most distinctive feature is cauliflory: small flowers emerge directly from the trunk and major branches rather than from new growth. Each ovoid fruit pod (15–30 cm long) contains 20–60 seeds embedded in sweet pulp. Beans are fermented for 5–7 days after harvest — a step critical to flavor and alkaloid development — then sun-dried and roasted.

'''''Theobroma cacao''''' L. is a small evergreen tree of the family Malvaceae, previously classified within Sterculiaceae before that family was subsumed into Malvaceae{{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=7713fe43}}. The genus ''Theobroma'' contains approximately 20 species, of which ''T. cacao'' is the sole species of major economic and pharmacological significance; ''T. grandiflorum'' (cupuaçu) is cultivated regionally in the Amazon but is pharmacologically distinct. Twenty-four synonyms have been documented, including ''Cacao minus'' Gaertn., ''Theobroma leiocarpum'' Bernoulli, and ''Theobroma pentagonum'' Bernoulli{{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=7600c97f}}. The species is native to the lowland rainforests of Brazil (northern regions), Colombia, Costa Rica, Ecuador, French Guiana, Guyana, Peru, Suriname, and Venezuela{{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=cdd11b27}}. Molecular evidence identifies the Upper Amazon as the primary center of domestication, approximately 5,450–5,300 BP{{cite|doi=10.1094/phyto-05-20-0178-rvw|anchor=f0ffef89}}. All commercial production derives from cultivated trees; wild populations persist in the Amazon basin but are not harvested at scale. In cultivation, ''T. cacao'' reaches 6–12 m in height. Pods are cauliflorous — borne directly on the trunk and major branches — and each contains 20–50 seeds (cacao beans) embedded in a sweet white mucilage. Three principal cultivar groups dominate global production: '''Criollo''' (fine/aromatic type, historically cultivated in pre-Columbian Mesoamerica, thin pod walls, low disease resistance), '''Forastero''' (bulk type, Amazon basin origin, representing approximately 80–90% of world production), and '''Trinitario''' (a natural Criollo × Amelonado Forastero hybrid originating in Trinidad){{cite|pubmed=12939635|anchor=eaa1a40e}}. These cultivar groups differ meaningfully in alkaloid and flavanol concentration profiles, with Criollo generally exhibiting the highest flavanol content. [[glossary:misidentification]] risk in commerce is low. [[effect:confusion]] with ''T. grandiflorum'' (cupuaçu) is possible in wild-harvested material but unlikely in commercial cocoa products. At the genus level, ''Herrania'' species have historically been confused with ''Theobroma'' in botanical collections{{cite|url=https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:320783-2|anchor=ee8936b2}}. Major producing regions include West Africa (Ivory Coast, Ghana, Cameroon — collectively accounting for the majority of global output), Southeast Asia (Indonesia, Malaysia, Vietnam), and Latin America (Ecuador, Brazil, Peru, Colombia).

===Dominant alkaloid: theobromine=== [[substance:theobromine]] (3,7-dimethylxanthine) is the dominant alkaloid in cocoa, present at roughly ten times the [[substance:caffeine]] concentration in cacao seeds{{cite|doi=10.1111/1750-3841.70979|anchor=a1ff8878}}. It blocks [[glossary:adenosine]] [[glossary:receptor|receptors]] and inhibits phosphodiesterases, raising alerting signals inside cells{{cite|doi=10.3390/ijms231810510|anchor=bf14d1f9}}{{cite|doi=10.3389/fphar.2015.00030|anchor=caabaab9}}. Compared to caffeine, theobromine penetrates the [[glossary:blood-brain-barrier]] less readily, producing gentler [[effect:stimulation]] and lower reinforcing potential{{cite|doi=10.3389/fphar.2015.00030|anchor=37a5d8e3}}. ===Caffeine and entourage interaction=== Caffeine contributes meaningfully to cocoa's [[substance_class:psychoactive/stimulant]] character despite its lower concentration, because it penetrates the brain more readily. Theobromine [[glossary:co-ingestion|co-ingestion]] increases epicatechin peak [[glossary:plasma-concentration|plasma levels]] by 21%, showing that cocoa's constituents interact pharmacokinetically{{cite|doi=10.1016/j.freeradbiomed.2023.01.003|anchor=ddb643c7}}. Theobromine is highly bioavailable (>85% from the cocoa matrix){{cite|doi=10.1039/d5fo05193b|anchor=f01f24e4}} and has an [[glossary:half-life]] of roughly 6–10 hours{{cite|doi=10.3389/fphar.2015.00030|anchor=5729e415}}{{flag|safety-citation-needed}}. ===Minor bioactives and variability=== Cocoa's polyphenols — principally epicatechin — produce vasodilation through a pathway independent of methylxanthine activity{{cite|doi=10.1016/j.vph.2015.05.011|anchor=8b70581a}}. Trace phenylethylamine and [[glossary:anandamide]]-like compounds have been detected; whether they reach pharmacologically active concentrations after digestion is unestablished{{cite|pubmed=8751435|anchor=ba93fb19}}{{cite|pubmed=10876983|anchor=06a8793e}}. Alkaloid concentrations vary substantially by variety and processing: fermentation reduces flavanols by 60–90%, and dark chocolate delivers proportionally higher methylxanthine loads than milk or white chocolate.

===Dominant alkaloid: theobromine=== [[substance:theobromine]] (3,7-dimethylxanthine) is the principal psychoactive constituent of cocoa, present at approximately ten times the concentration of [[substance:caffeine]] in cacao seeds{{cite|doi=10.1111/1750-3841.70979|anchor=fe36fabd}}. It belongs to the methylxanthine family and exerts its effects through [[glossary:adenosine]] A₁ and A₂A [[glossary:antagonism|receptor antagonism]] and phosphodiesterase [[glossary:inhibition]], raising intracellular cAMP{{cite|doi=10.3390/ijms231810510|anchor=c4b14c2c}}{{cite|doi=10.3389/fphar.2015.00030|anchor=803da465}}. Compared to caffeine, theobromine crosses the blood–brain barrier less readily, producing milder central [[effect:stimulation]] and lower reinforcing potential{{cite|doi=10.3389/fphar.2015.00030|anchor=89f2a068}}. ===Caffeine and entourage interaction=== Caffeine (1,3,7-trimethylxanthine) shares theobromine's [[glossary:receptor]] targets but is present at much lower concentrations in cocoa. Despite this, caffeine contributes meaningfully to cocoa's [[substance_class:psychoactive/stimulant]] profile because of its stronger [[glossary:brain-penetration|CNS penetration]]. Theobromine [[glossary:co-ingestion|co-ingestion]] has been shown to increase epicatechin [[glossary:cmax|peak plasma concentration]] by 21%, demonstrating a synergistic [[glossary:pharmacokinetic-interaction]] among cocoa constituents{{cite|doi=10.1016/j.freeradbiomed.2023.01.003|anchor=a5526fc8}}. ===Minor bioactives=== Cocoa's flavan-3-ol polyphenols — principally epicatechin — stimulate endothelial nitric oxide synthase, producing vasodilation through a pathway mechanistically distinct from the methylxanthine effects{{cite|doi=10.1016/j.vph.2015.05.011|anchor=3a9bee13}}. Trace amounts of phenylethylamine and [[glossary:anandamide]]-like N-acylethanolamines have been detected in cocoa; whether these reach pharmacologically active concentrations after [[glossary:ingestion|oral ingestion]] and [[glossary:first-pass-metabolism]] remains unestablished{{cite|pubmed=8751435|anchor=b29ef973}}{{cite|pubmed=10876983|anchor=7f22e2af}}. ===Variability=== Alkaloid and polyphenol concentrations vary substantially across cacao varieties (Criollo, Forastero, Trinitario), growing region, and processing method. Fermentation reduces flavanol content by 60–90%, and roasting further degrades heat-sensitive polyphenols. Dark chocolate with higher cocoa solids content delivers proportionally higher methylxanthine loads than milk chocolate or cocoa powder beverages. Unfermented "raw cacao" preparations retain higher flavanol concentrations but are more astringent and less palatable. ===Pharmacokinetics summary=== Theobromine exhibits high oral bioaccessibility exceeding 85% from the cocoa matrix{{cite|doi=10.1039/d5fo05193b|anchor=7dcfe732}}, with an [[glossary:half-life]] of approximately 6–10 hours{{cite|doi=10.3389/fphar.2015.00030|anchor=39a13818}}{{flag|safety-citation-needed}}. Epicatechin [[glossary:absorption]] is biphasic: a primary peak at approximately 1.8 hours (small intestinal absorption) and a secondary peak at approximately 5.3 hours (colonic microbial [[glossary:metabolite|metabolites]]), with mean [[glossary:bioavailability]] from cocoa of roughly 25% compared to approximately 82% from pure epicatechin{{cite|doi=10.1016/j.mam.2022.101146|anchor=80a3d962}}.

===Methylxanthines=== The dominant alkaloid in cacao is [[substance:theobromine]] (3,7-dimethylxanthine; C₇H₈N₄O₂, MW 180.16), present at concentrations that vary by cultivar and tissue type. In cocoa bean mucilage, theobromine content reaches 2.65% dry weight in Nacional × Trinitario varieties and 1.28% in Forastero (CCN-51) varieties{{cite|doi=10.3390/foods12132583|anchor=ba36fe3c}}. In finished artisanal chocolates spanning 36–100% declared cocoa content, HPLC quantification yields theobromine concentrations of 1.158–21.033 g/kg, with a strong positive linear correlation to cocoa percentage{{cite|doi=10.1111/1750-3841.70979|anchor=dfc33789}}. Dark chocolate at ≥70% cocoa solids typically contains 10–18 g theobromine per kilogram{{cite|doi=10.1111/1750-3841.70979|anchor=6b43f8c9}}. [[substance:caffeine]] (1,3,7-trimethylxanthine; C₈H₁₀N₄O₂, MW 194.19) is the secondary methylxanthine, present at approximately one-tenth the concentration of theobromine. Caffeine content in cocoa bean mucilage ranges from 0.35% (CCN-51) to 0.90% dry weight (Nacional × Trinitario){{cite|doi=10.3390/foods12132583|anchor=69869731}}. In finished chocolates, caffeine concentrations span 0.058–1.997 g/kg{{cite|doi=10.1111/1750-3841.70979|anchor=7fb0ac4a}}. Theobromine serves as the discriminating marker for cocoa content authentication; caffeine alone is insufficient for this purpose{{cite|doi=10.1111/1750-3841.70979|anchor=6a617ff9}}. Biosynthetically, caffeine production in ''Theobroma'' proceeds via xanthosine → 7-methylxanthosine → 7-methylxanthine → theobromine → caffeine. Theobromine is thus a biosynthetic precursor to caffeine in cacao, unlike in ''Coffea'' species where both alkaloids accumulate independently{{cite|pubmed=18068204|anchor=8926748f}}. ===Polyphenols=== The dominant polyphenols in unprocessed cacao are flavan-3-ols, principally epicatechin and catechin. Epicatechin has been quantified at 13.71 mg/L and catechin at 35.44 mg/g in cocoa mucilage (Nacional × Trinitario variety){{cite|doi=10.3390/foods12132583|anchor=6f4d9d65}}. Oligomeric procyanidins (condensed tannins), ranging from monomers through decamers, have been quantified by normal-phase HPLC with fluorescence [[glossary:detection]]{{cite|pubmed=10552788|anchor=61284b99}}. ===Minor bioactive constituents=== Phenylethylamine (β-phenylethylamine, PEA) is present in trace amounts as a biogenic amine formed during cacao bean fermentation via microbial [[substance_class:chemical/amino-acid]] decarboxylation. Rapid [[glossary:first-pass-metabolism|first-pass]] [[glossary:monoamine-oxidase]] [[glossary:metabolism]] in the gut and liver limits systemic [[glossary:bioavailability]] at dietary doses. No published human dose-response study demonstrates clinically meaningful PEA activity from cocoa consumption{{flag|citation-needed}}. Three N-acylethanolamines — including [[glossary:anandamide]] (N-arachidonoylethanolamine), N-oleoylethanolamide, and N-linoleoylethanolamide — have been identified in chocolate{{cite|pubmed=8751435|anchor=f70b82e3}}. These compounds can act as direct [[glossary:cb1-receptor]] [[glossary:agonist|agonists]] or indirectly prolong [[glossary:endogenous]] anandamide activity by inhibiting fatty acid amide hydrolase (FAAH){{cite|pubmed=8751435|anchor=e143667b}}. However, forensic investigation has confirmed that these N-acylethanolamines at concentrations present in chocolate do not cross-react with standard [[substance:cannabis]] immunoassay screening{{cite|pubmed=10876983|anchor=a4377604}}, and the quantities present are insufficient for clinically meaningful [[substance_class:psychoactive/cannabinoid]] effects at dietary doses{{cite|pubmed=11363932|anchor=1d0e9141}}. ===Processing effects on constituent ratios=== Fermentation, an essential post-harvest step, dramatically alters the flavanol profile while leaving methylxanthine concentrations relatively stable{{cite|doi=10.1007/s10068-017-0196-x|anchor=06750016}}. Roasting at higher temperatures (110–150°C) decreases soluble free phenolics while increasing bound phenolics in melanoidin fractions; Criollo beans exhibit the highest unroasted phenolic content{{cite|doi=10.1016/j.foodres.2018.08.028|anchor=fa96d3c7}}. Dutch (alkali) processing significantly reduces flavanol content in cocoa powder{{cite|doi=10.1111/j.1753-4887.2008.00114.x|anchor=9f376706}}. In dark chocolate manufacturing, milk [[glossary:protein-binding]] can reduce epicatechin bioavailability, while co-present theobromine increases epicatechin cmax by 21%{{cite|doi=10.1016/j.freeradbiomed.2023.01.003|anchor=71609511}}.

===Where it acts=== Cocoa's central effects arise primarily from [[substance:theobromine]] and [[substance:caffeine]] blocking [[glossary:adenosine]] A₁ and A₂A [[glossary:receptor|receptors]]. A₁ receptor [[glossary:blockade]] facilitates synaptic [[glossary:transmission]], while A₂A blockade modulates dopaminergic signaling in [[glossary:reward]] and motor [[glossary:circuit|circuits]]{{cite|doi=10.3390/ijms231810510|anchor=0a4c5680}}. Both methylxanthines also inhibit phosphodiesterases, increasing cAMP and cGMP levels with downstream effects on alertness, cardiac output, and smooth [[effect:muscle-relaxation]]{{cite|doi=10.3389/fphar.2015.00030|anchor=49719dcd}}{{cite|doi=10.3390/molecules21080974|anchor=eddda471}}. A separate vascular pathway operates through cocoa flavanols: epicatechin stimulates endothelial nitric oxide synthase, producing vasodilation independent of the methylxanthine mechanism{{cite|doi=10.1016/j.vph.2015.05.011|anchor=e8fb346d}}. ===What it changes=== The dual adenosine blockade confers neuroprotection against amyloid-β₁₋₄₂-induced neuronal loss ''in vitro''{{cite|doi=10.3390/ijms231810510|anchor=469cd721}}, and methylxanthines promote sustained cognitive performance in [[glossary:animal-model|animal models]] of neurodegeneration{{cite|doi=10.1007/s11064-018-2492-0|anchor=44064771}}. Theobromine also suppresses capsaicin-induced cough through peripheral [[glossary:inhibition]] of vagus nerve sensory depolarization — a mechanism distinct from its adenosine receptor activity{{cite|pubmed=15548587|anchor=c8b0aafe}}. [[glossary:tolerance]] to caffeine's subjective and sleep-disrupting effects develops with repeated habitual use{{cite|pubmed=11326548|anchor=28c79dcb}}, which likely applies to cocoa's [[substance_class:psychoactive/stimulant]] profile at heavy consumption levels. {{DiscoverMore|Open Questions}} * No neuroimaging studies (fMRI, PET, EEG) specifically examining brain activity during acute cocoa or chocolate consumption have been published. * Whether cocoa's trace N-acylethanolamines produce measurable endocannabinoid-like [[glossary:central-nervous-system|CNS]] effects at dietary doses remains unestablished. * The preparation-specific [[glossary:pharmacokinetics]] of high-dose "ceremonial cacao" have not been characterized. {{/DiscoverMore}}

===Where it acts=== [[substance:theobromine]] and [[substance:caffeine]] block [[glossary:adenosine]] [[glossary:receptor|receptors]] in the brain, reducing the [[glossary:fatigue]] signal and shifting [[glossary:dopamine]] activity in [[glossary:reward]] and motor [[glossary:circuit|circuits]]{{cite|doi=10.3390/ijms231810510|anchor=1dd244fa}}. Both also inhibit phosphodiesterases, amplifying cellular alerting signals with downstream effects on [[effect:wakefulness]], [[glossary:heart-rate]], and smooth [[effect:muscle-relaxation]]{{cite|doi=10.3389/fphar.2015.00030|anchor=66387309}}{{cite|doi=10.3390/molecules21080974|anchor=5e77b9b2}}. A separate vascular mechanism operates through cocoa's epicatechin, which [[glossary:trigger|triggers]] nitric oxide production in blood vessel walls, causing vasodilation{{cite|doi=10.1016/j.vph.2015.05.011|anchor=c5bf2764}}. ===What it changes=== Adenosine receptor [[glossary:blockade]] shows neuroprotective effects against amyloid-related neuronal loss in laboratory studies{{cite|doi=10.3390/ijms231810510|anchor=1aafd387}}, and methylxanthines support cognitive performance in [[glossary:animal-model|animal models]] of neurodegeneration{{cite|doi=10.1007/s11064-018-2492-0|anchor=3a82002d}}. Theobromine also reduces cough by quieting sensory signals in the vagus nerve — a mechanism distinct from its adenosine effects{{cite|pubmed=15548587|anchor=5f851a54}}. [[glossary:tolerance]] to caffeine's [[substance_class:psychoactive/stimulant]] and sleep-disrupting effects develops with repeated use{{cite|pubmed=11326548|anchor=2546531f}} and likely extends to cocoa's stimulant profile at heavy consumption levels. {{DiscoverMore|Open Questions}} * No neuroimaging studies (fMRI, PET, EEG) specifically examining brain activity during acute cocoa or chocolate consumption have been published. * Whether cocoa's trace N-acylethanolamines produce measurable endocannabinoid-like [[glossary:central-nervous-system|CNS]] effects at dietary doses remains unestablished. * The preparation-specific [[glossary:pharmacokinetics]] of high-dose "ceremonial cacao" have not been characterized. {{/DiscoverMore}}

Cocoa's defining quality is subtlety. At typical dietary doses, it produces a gentle, sustained [[effect:wakefulness]] paired with mild mood [[glossary:elevation]] and diffuse physical [[glossary:warmth]]. The experience shifts by preparation: a cocoa powder beverage delivers gradual, even [[effect:stimulation]], while dark chocolate offers a more concentrated methylxanthine load alongside orosensory [[glossary:pleasure]] and satiety that blur the line between pharmacological and sensory experience. Among common methylxanthine preparations, cocoa sits at the lowest [[glossary:intensity]]. Its [[substance_class:psychoactive/stimulant]] profile is substantially milder than coffee — consistent with [[substance:theobromine]]'s weaker [[glossary:brain-penetration]] and the roughly tenfold lower [[substance:caffeine]] content per serving{{cite|doi=10.3389/fphar.2015.00030|anchor=862c4496}}. The overall arc — a long, low-grade alertness shaped by theobromine's 6–10 hour [[glossary:half-life]] — more closely resembles mild green tea than strong coffee.

===Cocoa powder (oral, hot beverage)=== A standard serving consists of 5–15 g cocoa powder dissolved in hot water or milk. At a 15 g serving, estimated methylxanthine content is approximately 150–300 mg [[substance:theobromine]] and 10–30 mg [[substance:caffeine]], based on HPLC quantification of commercial cocoa products{{cite|doi=10.1111/1750-3841.70979|anchor=d7b3918c}}. Onset of [[substance_class:psychoactive/stimulant]] effects occurs at approximately 30–60 minutes; flavanol-mediated cardiovascular effects (vasodilation, improved flow-mediated dilation) develop within 2 hours{{cite|doi=10.1016/j.vph.2015.02.010|anchor=044e1e18}}{{cite|doi=10.1016/j.vph.2015.05.011|anchor=d0dbf456}}. Total subjective stimulant duration is approximately 2–4 hours. Dutch-processed (alkalized) cocoa powder retains most methylxanthine content but has substantially reduced flavanol concentrations relative to natural cocoa powder{{cite|doi=10.1111/j.1753-4887.2008.00114.x|anchor=e4336b7b}}. ===Dark chocolate (oral, solid)=== A 100 g serving of dark chocolate (70–85% cocoa solids) delivers approximately 400–800 mg theobromine and 40–80 mg caffeine{{cite|doi=10.1111/1750-3841.70979|anchor=87a19a6a}}. Sub-chronic daily consumption of dark chocolate for 30 days increased [[glossary:plasma]] theobromine concentrations, elevated nerve growth factor (NGF), and improved cognitive performance on Stroop and cancellation tasks in a [[glossary:controlled-study]]{{cite|doi=10.3390/nu11112800|anchor=9036f97c}}. Onset of stimulant effects: 30–60 minutes; peak: 1–3 hours; total duration: 3–6 hours. Milk chocolate contains lower cocoa solids (typically 25–40%) and proportionally lower methylxanthine content; milk proteins may additionally reduce epicatechin [[glossary:bioavailability]]{{cite|doi=10.1111/j.1753-4887.2008.00114.x|anchor=e28c918f}}. ===Standardized cocoa flavanol extract (oral, supplement)=== Clinical trials have employed standardized cocoa flavanol extracts at doses of 500 mg flavanols/day (COSMOS-Mind){{cite|doi=10.1002/alz.12767|anchor=42105cbc}} and 600–1,350 mg flavanols/day for acute cardiovascular endpoints{{cite|doi=10.1093/ajcn/nqac055|anchor=56df87c9}}. These preparations isolate the flavanol fraction and may not replicate the full methylxanthine and polyphenol profile of whole cocoa products. A Cochrane meta-analysis found that flavanol-rich cocoa produced an approximate 2 mmHg reduction in systolic [[glossary:blood-pressure]] compared with low-flavanol controls (moderate quality evidence){{cite|doi=10.1002/14651858.cd008893.pub3|anchor=111f59f0}}. ===Potency variability=== Theobromine and flavanol content varies substantially across cultivars, growing regions, and processing methods. Criollo varieties generally exhibit higher flavanol content than Forastero varieties{{cite|doi=10.1016/j.foodres.2018.08.028|anchor=3016abe2}}. Roasting temperature, fermentation duration, and alkali processing each independently modulate the final constituent profile of commercial cocoa products{{cite|doi=10.1111/j.1753-4887.2008.00114.x|anchor=49d69645}}. No standardized psychoactive dose tiers (threshold, common, strong, heavy) have been published for any cocoa preparation. See the Dose by preparation card for estimated ranges based on available HPLC data. {{Info}}No published [[glossary:dose-finding-study|dose-finding studies]] characterizing psychoactive dose thresholds for cocoa preparations exist. All dose estimates are derived from analytical chemistry quantification of methylxanthine content in commercial products and should be interpreted as approximations subject to substantial inter-product variability.{{/Info}}

Cocoa's experiential character is defined by subtlety. At typical dietary doses, it produces a gentle, sustained [[effect:wakefulness]] paired with mild mood [[glossary:elevation]] and a diffuse physical [[glossary:warmth]]. The experience varies by preparation: cocoa powder beverages deliver a gradual, even [[effect:stimulation]], while dark chocolate provides a more concentrated methylxanthine load alongside orosensory [[glossary:pleasure]] and satiety effects that blur the line between pharmacological and sensory experience. [[glossary:set-and-setting]] exert minimal influence compared to stronger psychoactive substances; preparation type and dose are the primary modifiers. Among commonly consumed methylxanthine preparations, cocoa sits at the lowest [[glossary:intensity]] position. Its [[substance_class:psychoactive/stimulant]] profile is substantially milder than coffee's, consistent with [[substance:theobromine]]'s weaker [[glossary:brain-penetration|CNS penetration]] and the approximately tenfold lower [[substance:caffeine]] content per serving{{cite|doi=10.3389/fphar.2015.00030|anchor=96165957}}. The overall arc — a long, low-grade alertness curve shaped by theobromine's 6–10 hour [[glossary:half-life]] — more closely resembles a mild green tea than a strong coffee.

===Toxicity=== [[substance:theobromine]] is safe at typical human dietary exposures. No published cases of human hospitalization or [[glossary:fatality]] from normal cocoa or chocolate consumption have been identified. A human [[glossary:lethal-dose]] is estimated at approximately 1,000 mg/kg, but this figure has not been verified in primary published studies{{flag|safety-citation-needed}}. Theobromine is '''severely toxic to dogs and cats''' due to their much slower [[glossary:elimination]] of the compound. A documented case in a Corgi at 88.3 mg/kg body weight produced severe [[glossary:tachycardia]], [[glossary:tremor|tremors]], [[glossary:seizure|seizures]], and prolonged neurological effects{{cite|pubmed=41030422|anchor=b27c75e6}}. Any cocoa or chocolate [[glossary:ingestion]] by companion animals requires immediate veterinary evaluation. ====Contaminant and adulterant risk==== '''Cadmium''' is the most significant [[glossary:contamination|contaminant]] concern. Cacao plants bioaccumulate cadmium from soil, and Latin American growing regions — Peru, Ecuador, Colombia, Bolivia — have naturally elevated soil cadmium{{cite|doi=10.1021/acs.jafc.9b08295|anchor=8ed25f39}}{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=3cb0e882}}. Cadmium accumulates in the kidneys over decades — biological [[glossary:half-life]] 10–30 years — and poses heightened risk to children, who consume more chocolate per body weight and have longer remaining exposure horizons{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=5305ad82}}{{cite|doi=10.1016/j.fct.2025.115799|anchor=325f3b10}}. The EU enforces limits of 0.3 mg/kg for cocoa powder and 0.1 mg/kg for milk chocolate. Dark chocolate contains higher cadmium concentrations than milk or white chocolate due to higher cocoa solids content{{cite|doi=10.1016/j.fct.2025.115799|anchor=cc83b2bf}}. Disproportionate risk has been noted for Black and Hispanic children due to compounding environmental lead exposures{{cite|doi=10.1016/j.fct.2025.115799|anchor=35aca32c}}. '''Lead''' has been documented at measurable levels in dark chocolate, with some samples exceeding international limits; contamination is largely post-harvest, from environmental deposition during open-air drying{{cite|doi=10.1021/acs.jafc.9b08295|anchor=1250ac82}}. '''Arsenic''' has been detected in cocoa powder at a mean concentration of 0.06 mg/kg{{flag|citation-needed}}. No cadmium content is routinely reported on product labels in most jurisdictions{{flag|safety-citation-needed}}. ===Psychological Risks=== At typical dietary doses, cocoa presents minimal acute [[glossary:psychological-risk]]. High [[substance:caffeine]] intake — achievable through heavy dark chocolate consumption — can cause dose-dependent [[effect:anxiety]], [[effect:insomnia]], and tremor, with individual variation driven by genetic differences in caffeine [[glossary:metabolism]]{{cite|doi=10.3389/fphar.2015.00030|anchor=89705b54}}. No [[glossary:psychotomimetic|psychotomimetic effects]] have been documented at dietary doses. The [[glossary:hypothesis]] that cocoa's [[glossary:anandamide]]-like compounds produce [[substance:cannabis]]-like effects has not been confirmed in human behavioral studies{{cite|pubmed=8751435|anchor=0b061d87}}{{cite|pubmed=10876983|anchor=0917d7ae}}{{cite|pubmed=11363932|anchor=927cd341}}. Chocolate [[effect:craving]] is a documented behavioral phenomenon, but whether it reflects pharmacological [[glossary:reinforcement]] or conditioned learned response remains contested{{flag|citation-needed}}. ===Tolerance & Dependence=== [[glossary:tolerance]] to caffeine's [[substance_class:psychoactive/stimulant]] and sleep-disrupting effects develops with repeated habitual use{{cite|pubmed=11326548|anchor=1516f4f0}}. This likely extends to cocoa's stimulant effects at heavy consumption levels. No tolerance phenomenon specific to theobromine has been documented. Caffeine [[glossary:physical-dependence]] is well established. [[glossary:withdrawal]] begins 12–24 hours after last dose, [[glossary:peak|peaks]] at days 1–2, and resolves within 5–7 days. Symptoms include [[effect:headache]] (most common), [[glossary:fatigue]], [[effect:irritability]], and decreased alertness{{cite|pubmed=11326548|anchor=2e7aa760}}{{cite|pubmed=3772801|anchor=419ae090}}. DSM-IV caffeine [[glossary:dependence]] criteria are met in 9–30% of heavy users, with dependence possible at doses as low as 100 mg/day{{cite|pubmed=11326548|anchor=c1d0521d}}. A typical 100 g serving of dark chocolate contains roughly 40–80 mg caffeine — below a standard coffee but approaching the dependence threshold with daily heavy consumption. No dependence syndrome specific to theobromine has been documented{{cite|doi=10.3389/fphar.2015.00030|anchor=259800bd}}. ===Drug Interactions=== No published [[glossary:case-report|case reports]] of clinically significant interactions from dietary cocoa have been identified. The following interactions are pharmacologically plausible but unconfirmed in clinical cases. '''MAO inhibitors:''' Irreversible [[substance_class:pharmacological/monoamine-oxidase-inhibitor|monoamine oxidase inhibitors]] (phenelzine, tranylcypromine) reduce [[glossary:first-pass-metabolism]] of dietary tyramine and phenylethylamine. Chocolate contains trace amounts of both from fermentation, which could theoretically [[glossary:trigger]] a dangerous [[glossary:blood-pressure]] spike — though no published case report specifically implicating cocoa has been identified{{flag|safety-citation-needed}}. '''Adenosine (therapeutic):''' Caffeine and theobromine block the effects of [[glossary:adenosine]] used in cardiac stress testing and heart rhythm management. High cocoa intake before adenosine-based cardiac procedures could reduce drug [[glossary:efficacy]]{{flag|safety-citation-needed}}. '''CYP-mediated interactions:''' Epicatechin [[glossary:metabolite|metabolites]] may affect [[glossary:cyp3a4]] activity in laboratory studies{{cite|doi=10.1016/j.mam.2022.101146|anchor=68ffd339}}, though clinical significance at dietary doses is unestablished. Caffeine is metabolized by [[glossary:cyp1a2]]; drugs that affect this [[glossary:enzyme]] — fluvoxamine, ciprofloxacin, or smoking — will alter caffeine and theobromine [[glossary:clearance]] from cocoa consumption{{cite|pubmed=18068204|anchor=ad1840c4}}. {{Info}}All interaction [[glossary:severity]] assessments for cocoa remain unrated due to the absence of clinical case reports or primary [[glossary:pharmacokinetic-interaction]] studies specific to dietary cocoa products.{{/Info}} ===Contraindications=== '''Pregnancy:''' Each 100 mg increment in daily caffeine intake is associated with a 14% increase in spontaneous abortion risk, a 19% increase in stillbirth risk, and a 10% increase in small-for-gestational-age birth risk{{cite|doi=10.1007/s10654-014-9944-x|anchor=135d8650}}. WHO and UK NHS guidelines recommend ≤200 mg caffeine per day during [[glossary:pregnancy]]. Heavy dark chocolate consumption (200–300 g daily of 70%+ chocolate) can contribute 80–240 mg caffeine toward this limit; pregnant individuals should count dark chocolate toward total daily caffeine intake. '''Pediatric populations:''' Cadmium bioaccumulation risk is heightened in children. Dark chocolate is not recommended as a primary food for young children based on heavy metal content{{cite|doi=10.1016/j.fct.2025.115799|anchor=1ec90bc0}}{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=6dde67ff}}. '''Companion animals:''' Theobromine is severely toxic to dogs and cats. Any cocoa or chocolate ingestion by companion animals warrants immediate veterinary evaluation{{cite|pubmed=41030422|anchor=e6f7e1aa}}. '''Hepatic impairment:''' Impaired liver function reduces caffeine and theobromine clearance, prolonging stimulant effects and increasing [[glossary:accumulation]] risk{{flag|safety-citation-needed}}. '''MAO inhibitor use:''' Patients on irreversible [[glossary:monoamine-oxidase|MAO]] [[glossary:inhibitor|inhibitors]] should be counseled about potential tyramine and phenylethylamine content in chocolate, though clinical significance for cocoa-specific consumption is unconfirmed.

===Toxicity=== [[substance:theobromine]] is considered safe at typical human dietary exposures. No published [[glossary:case-report|case reports]] of human hospitalization or [[glossary:fatality]] from normal cocoa or chocolate consumption were identified in the literature. [[glossary:secondary-source|Secondary sources]] estimate a human [[glossary:lethal-dose]] of approximately 1,000 mg/kg, but this value has not been independently verified in primary published studies{{flag|safety-citation-needed}}. Theobromine is '''severely toxic to dogs and cats''' due to their markedly slower N-demethylation capacity. A documented case of chocolate [[glossary:ingestion]] in a Corgi at 88.3 mg/kg body weight produced severe [[glossary:tachycardia]], [[glossary:tremor|tremors]], [[glossary:seizure|seizures]], and prolonged neurological [[glossary:sequela|sequelae]]{{cite|pubmed=41030422|anchor=7b2c5733}}. Any cocoa or chocolate ingestion by companion animals warrants immediate veterinary evaluation. ====Contaminant and adulterant risk==== '''Cadmium''' is the most significant [[glossary:contamination|contaminant]] concern for commercial cocoa products. Cacao plants bioaccumulate cadmium from soil, with Latin American production regions (Peru, Ecuador, Colombia, Bolivia) exhibiting naturally elevated soil cadmium levels{{cite|doi=10.1021/acs.jafc.9b08295|anchor=12ddd765}}{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=c06608e1}}. Cadmium has a biological [[glossary:half-life]] of 10–30 years and accumulates in renal tissue, posing heightened risk to children — the primary consumers of chocolate products{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=2e08c818}}{{cite|doi=10.1016/j.fct.2025.115799|anchor=223fd237}}. The EU enforces cadmium limits of 0.3 mg/kg for cocoa powder and 0.1 mg/kg for milk chocolate. Dark chocolate contains higher cadmium concentrations than milk or white chocolate due to higher cocoa solids content{{cite|doi=10.1016/j.fct.2025.115799|anchor=f3f5c21f}}. Disproportionate health risk has been noted for Black and Hispanic children due to compounding environmental lead exposures{{cite|doi=10.1016/j.fct.2025.115799|anchor=468848e7}}. '''Lead''' has been documented at measurable levels in dark chocolate, with some samples exceeding international limits. Contamination is largely post-harvest, from environmental deposition during open-air drying{{cite|doi=10.1021/acs.jafc.9b08295|anchor=91e87e19}}. '''Arsenic''' has been detected in cocoa powder at a mean concentration of 0.06 mg/kg{{flag|citation-needed}}. No published data on pesticide residues or mycotoxin contamination in commercial cocoa products were identified{{flag|safety-citation-needed}}. No standardized consumer-facing heavy metal disclosure regime exists for cocoa products in most jurisdictions; cadmium content is not routinely reported on product labels. ===Psychological Risks=== At typical dietary doses, cocoa presents minimal acute [[glossary:psychological-risk]]. High [[substance:caffeine]] intake — achievable through heavy dark chocolate consumption — can produce dose-dependent [[effect:anxiety]], [[effect:insomnia]], and tremor, with individual variation modulated by [[glossary:cyp1a2]] [[glossary:genetic-polymorphism|polymorphisms]] and [[glossary:adenosine]] [[glossary:receptor]] [[glossary:sensitivity]]{{cite|doi=10.3389/fphar.2015.00030|anchor=69241cc3}}. No [[glossary:psychotomimetic|psychotomimetic effects]] have been documented at dietary doses. The [[glossary:hypothesis]] that cocoa N-acylethanolamines produce [[substance:cannabis]]-like [[index:effects|subjective effects]] has not been confirmed in human behavioral studies{{cite|pubmed=8751435|anchor=02dac8a0}}{{cite|pubmed=10876983|anchor=55c60b9a}}{{cite|pubmed=11363932|anchor=9152997f}}. Chocolate [[effect:craving]] is documented as a behavioral phenomenon, but whether it reflects pharmacological [[glossary:reinforcement]], nutritional need, or conditioned learned response remains contested{{flag|citation-needed}}. ===Tolerance & Dependence=== [[glossary:tolerance]] to the subjective and sleep-disrupting effects of caffeine develops with repeated habitual use{{cite|pubmed=11326548|anchor=df9ff18b}}. This tolerance likely extends to cocoa's [[substance_class:psychoactive/stimulant]] effects at heavy consumption levels. No tolerance phenomenon specific to theobromine has been documented. Caffeine [[glossary:physical-dependence]] is well established. [[glossary:withdrawal]] symptoms begin 12–24 hours after last dose, peak at days 1–2, and resolve within 5–7 days. Primary symptoms include [[effect:headache]] (most common), [[glossary:fatigue]], [[effect:irritability]], decreased alertness, and flu-like symptoms{{cite|pubmed=11326548|anchor=bbc41c0d}}{{cite|pubmed=3772801|anchor=b80d3277}}. DSM-IV caffeine [[glossary:dependence]] criteria are met in 9–30% of heavy caffeine users, with dependence possible at doses as low as 100 mg/day{{cite|pubmed=11326548|anchor=207074c7}}. A typical dark chocolate serving delivers approximately 40–80 mg caffeine per 100 g — below a standard coffee serving (~95 mg) but approaching the dependence threshold with daily heavy consumption. No dependence syndrome or withdrawal phenomenon specific to theobromine has been documented; theobromine has fewer [[glossary:central-nervous-system|CNS]] effects and lower reinforcing potential than caffeine{{cite|doi=10.3389/fphar.2015.00030|anchor=a09e9671}}. ===Drug Interactions=== No published case reports of clinically significant herb–[[glossary:drug-interaction|drug interactions]] specifically from dietary cocoa consumption were identified. The following interactions are pharmacologically plausible but lack clinical case report confirmation. '''MAO inhibitors:''' Irreversible [[substance_class:pharmacological/monoamine-oxidase-inhibitor|monoamine oxidase inhibitors]] (phenelzine, tranylcypromine) reduce [[glossary:first-pass-metabolism]] of dietary tyramine and phenylethylamine. Chocolate contains trace amounts of both biogenic amines from fermentation, which could theoretically precipitate a hypertensive crisis, though no published case report specifically implicating cocoa has been identified{{flag|safety-citation-needed}}. '''Adenosine (therapeutic):''' Caffeine and theobromine pharmacodynamically oppose the effects of therapeutic adenosine used in cardiac stress testing and supraventricular tachycardia management. High cocoa intake before adenosine-based cardiac procedures could attenuate drug [[glossary:efficacy]]{{flag|safety-citation-needed}}. '''CYP-mediated interactions:''' Epicatechin [[glossary:metabolite|metabolites]] may modulate [[glossary:cyp3a4]] and P-glycoprotein activity ''in vitro''{{cite|doi=10.1016/j.mam.2022.101146|anchor=eff1f6e8}}. Clinical significance at dietary cocoa doses has not been established. Caffeine is metabolized by CYP1A2; drugs that inhibit or induce CYP1A2 (fluvoxamine, ciprofloxacin, smoking) will alter caffeine and theobromine [[glossary:clearance]] from cocoa consumption{{cite|pubmed=18068204|anchor=41fc9b4d}}. {{Info}}All interaction [[glossary:severity]] assessments for cocoa remain unrated due to the absence of clinical case reports or primary [[glossary:pharmacokinetic-interaction]] studies specific to dietary cocoa products.{{/Info}} ===Contraindications=== '''Pregnancy:''' Each 100 mg increment in daily caffeine intake is associated with a 14% increase in spontaneous abortion risk, a 19% increase in stillbirth risk, and a 10% increase in small-for-gestational-age birth risk{{cite|doi=10.1007/s10654-014-9944-x|anchor=f10f4d58}}. WHO and UK NHS guidelines recommend ≤200 mg caffeine/day during [[glossary:pregnancy]]. Heavy dark chocolate consumption (200–300 g daily of 70%+ cocoa chocolate) could contribute 80–240 mg caffeine toward this limit; pregnant individuals should count dark chocolate toward total daily caffeine intake. '''Pediatric populations:''' Cadmium bioaccumulation risk is heightened in children due to lower body mass and longer remaining exposure horizons. Dark chocolate is not recommended as a primary food for young children on the basis of heavy metal content{{cite|doi=10.1016/j.fct.2025.115799|anchor=d7d0bca5}}{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=2b470fb0}}. '''Companion animals:''' Theobromine is severely toxic to dogs and cats. Any cocoa or chocolate ingestion by companion animals warrants immediate veterinary evaluation{{cite|pubmed=41030422|anchor=32c4a11c}}. '''Hepatic impairment:''' CYP1A2 is hepatically expressed. Impaired liver function will reduce caffeine and theobromine clearance, prolonging stimulant effects and increasing [[glossary:accumulation]] risk{{flag|safety-citation-needed}}. '''MAO inhibitor use:''' Patients taking irreversible monoamine oxidase inhibitors should be counseled regarding potential tyramine and phenylethylamine content in chocolate, though the clinical significance remains unconfirmed for cocoa-specific consumption.

====Cocoa powder beverage (oral)==== '''Cocoa powder beverage''' is the simplest preparation: unsweetened cocoa powder mixed into hot water or milk. A typical serving uses 5–15 g of powder, delivering a moderate [[substance:theobromine]] dose with relatively low [[substance:caffeine]] (roughly 5–20 mg caffeine per cup, depending on powder grade). Onset is gradual, typically 20–40 minutes, with peak effects at 1–2 hours and a total duration of 2–4 hours. The [[substance_class:psychoactive/stimulant]] character is mild and even. Dutched (alkali-processed) cocoa retains methylxanthines but loses a significant fraction of flavanols; natural-process powder preserves more polyphenol content. ====Dark chocolate (oral)==== '''Dark chocolate''' (70%+ cocoa solids) delivers the highest methylxanthine load of standard preparations. A 50 g serving of 85% dark chocolate contains approximately 200–300 mg theobromine and 20–40 mg caffeine. Onset occurs within 20–45 minutes, with effects lasting 3–6 hours due to the fat matrix slowing [[glossary:absorption]]. The experience combines pharmacological [[effect:stimulation]] with significant orosensory [[glossary:pleasure]] and satiety. Cadmium and lead concentrations are highest in dark chocolate due to elevated cocoa solids content{{cite|doi=10.1021/acs.jafc.9b08295|anchor=972fa48d}}{{cite|doi=10.1016/j.fct.2025.115799|anchor=da669881}}. ====Milk and white chocolate (oral)==== '''Milk chocolate''' contains lower cocoa solids (typically 25–40%) and correspondingly lower methylxanthine concentrations — roughly one-third to one-half the theobromine of equivalent dark chocolate servings. White chocolate contains cocoa butter but negligible cocoa solids, and its methylxanthine content is pharmacologically insignificant. Neither preparation is relevant as a psychoactive substance at normal serving sizes. ====Ceremonial cacao (oral)==== '''Ceremonial cacao''' preparations use minimally processed, often unroasted cacao paste at doses of 28–42 g (1–1.5 oz) dissolved in hot water. These doses deliver substantially higher methylxanthine and flavanol loads than standard cocoa beverages. Proponents report more pronounced stimulation, mood [[glossary:elevation]], and cardiovascular sensation ([[glossary:warmth]], flushing). The preparation-specific [[glossary:pharmacokinetics]] of ceremonial cacao have not been clinically characterized, and whether the reported effects exceed what standard dose–response curves for theobromine and caffeine would predict remains an open question. ====Standardized flavanol extract (oral)==== '''Standardized cocoa flavanol extracts''' (e.g., CocoaVia) deliver a defined flavanol dose — typically 500 mg epicatechin equivalents per serving — with minimal methylxanthine content. These are the preparations used in clinical trials such as COSMOS{{cite|doi=10.1093/ajcn/nqac055|anchor=d29a8232}}{{cite|doi=10.1002/alz.12767|anchor=c0a9122b}}. They produce negligible stimulant effects and are used for cardiovascular and cognitive endpoints rather than for psychoactive purposes. Per-preparation dose tiers, timelines, and [[glossary:bioavailability]] data are in the Dose · by preparation card on this page.

====Cocoa powder beverage (oral)==== '''Cocoa powder beverage''' — unsweetened cocoa powder mixed into hot water or milk. A typical serving uses 5–15 g of powder, delivering a moderate [[substance:theobromine]] dose with roughly 5–20 mg [[substance:caffeine]] per cup. Onset is gradual (20–40 minutes), peak effects at 1–2 hours, total duration 2–4 hours. Dutched (alkali-processed) powder retains methylxanthines but loses a significant fraction of flavanols; natural-process powder preserves more polyphenol content. ====Dark chocolate (oral)==== '''Dark chocolate''' (70%+ cocoa solids) delivers the highest methylxanthine load of standard preparations. A 50 g serving of 85% dark chocolate contains approximately 200–300 mg theobromine and 20–40 mg caffeine. Onset occurs within 20–45 minutes, with effects lasting 3–6 hours as the fat matrix slows [[glossary:absorption]]. Cadmium and lead concentrations are highest in dark chocolate due to elevated cocoa solids{{cite|doi=10.1021/acs.jafc.9b08295|anchor=55366d51}}{{cite|doi=10.1016/j.fct.2025.115799|anchor=35a67f3e}}. ====Milk and white chocolate (oral)==== '''Milk chocolate''' contains lower cocoa solids (25–40%) and roughly one-third to one-half the theobromine of equivalent dark chocolate servings. '''White chocolate''' contains cocoa butter but negligible cocoa solids, with pharmacologically insignificant methylxanthine content. Neither preparation functions as a meaningful psychoactive at normal serving sizes. ====Ceremonial cacao (oral)==== '''Ceremonial cacao''' uses minimally processed cacao paste at doses of 28–42 g dissolved in hot water — substantially more theobromine and caffeine than a standard cocoa beverage. Users report more pronounced [[effect:stimulation]], mood [[glossary:elevation]], and cardiovascular sensation ([[glossary:warmth]], flushing). The preparation-specific [[glossary:pharmacokinetics]] have not been clinically characterized, and whether reported effects exceed standard dose–response predictions for theobromine and caffeine remains an open question. ====Standardized flavanol extract (oral)==== '''Standardized cocoa flavanol extracts''' (e.g., CocoaVia) deliver a defined flavanol dose — typically 500 mg epicatechin equivalents per serving — with minimal methylxanthine content. These are the preparations used in COSMOS and related clinical trials{{cite|doi=10.1093/ajcn/nqac055|anchor=bb0b5d5e}}{{cite|doi=10.1002/alz.12767|anchor=e13ad214}}. They produce negligible [[substance_class:psychoactive/stimulant]] effects and are used for cardiovascular and cognitive endpoints rather than psychoactive purposes. Onset and [[glossary:intensity]] differ substantially between preparations — ceremonial cacao and dark chocolate take 20–45 minutes to reach peak effect, while flavanol extracts produce no meaningful stimulation at all.

===Forms & Identification=== Cocoa products are sold as food commodities and are not subject to the [[glossary:adulterant|adulteration]] risks typical of unregulated substances. However, cadmium and lead [[glossary:contamination]] is documented in dark chocolate and cocoa powder{{cite|doi=10.1021/acs.jafc.9b08295|anchor=278650aa}}. Third-party testing programs (ConsumerLab, As You Sow) publish heavy metal results for commercial chocolate brands. Those consuming dark chocolate daily — especially children — should choose brands with published Certificates of Analysis or sourced from lower-cadmium regions (West Africa generally shows lower cadmium than Latin American origins). For ceremonial cacao products sold outside conventional food retail, provenance and processing transparency are less standardized. No regulatory framework requires heavy metal disclosure for these products in most jurisdictions. ===Set & Setting=== Cocoa's effects are mild enough that set-and-setting considerations are minimal for standard dietary consumption. For ceremonial cacao sessions — which use substantially higher doses in group ritual contexts — participants should be aware that elevated methylxanthine loads can produce noticeable cardiovascular [[effect:stimulation]]: [[glossary:heart-rate]] increase, flushing, [[glossary:warmth]]. Individuals with [[substance:caffeine]] [[glossary:sensitivity]], [[effect:anxiety]] [[glossary:disorder|disorders]], or cardiovascular conditions should approach high-dose preparations cautiously. {{Guideline}} ===Guidelines=== * '''Start low with new preparations.''' Ceremonial cacao doses (28–42 g paste) deliver significantly more [[substance:theobromine]] and caffeine than a standard cocoa beverage. Begin with half a ceremonial dose if unfamiliar with the preparation. * '''Count dark chocolate toward daily caffeine intake.''' A 100 g serving of 85% dark chocolate contains roughly 40–80 mg caffeine. Those monitoring caffeine for sleep, anxiety, or [[glossary:pregnancy]] should track this. * '''Choose tested products for regular consumption.''' When consuming dark chocolate or cocoa powder daily, prefer brands with published third-party heavy metal testing. Rotate sources to reduce single-origin contaminant [[glossary:accumulation]]. * '''Time consumption appropriately.''' Theobromine's 6–10 hour [[glossary:half-life]] means late-afternoon or evening consumption — especially of dark chocolate — can interfere with sleep in caffeine-sensitive individuals. * '''Keep all cocoa and chocolate products away from dogs and cats.''' Theobromine is severely toxic to companion animals at doses easily reached by a single chocolate bar{{cite|pubmed=41030422|anchor=76a99788}}. {{/Guideline}} {{Emergency}} ===Emergency Response=== '''Recognizing an emergency in humans:''' Cocoa-related emergencies are exceedingly rare at dietary doses. Red flags include severe [[glossary:chest-pain]], heart palpitations, difficulty breathing, or signs of allergic reaction (swelling, hives, throat tightness) after consumption. '''Immediate steps:''' * '''1.''' Call emergency services (911 / 112 / local equivalent) if the person experiences chest pain, difficulty breathing, or [[glossary:loss-of-consciousness]]. * '''2.''' Keep the person calm, seated, and breathing steadily. * '''3.''' Note what was consumed, how much, and when. '''What to tell the dispatcher:''' Substance consumed (type of chocolate or cacao product), approximate amount, time of consumption, and current symptoms. Mention any [[glossary:medication|medications]] the person takes — particularly [[substance_class:pharmacological/monoamine-oxidase-inhibitor|monoamine oxidase inhibitors]] or cardiac medications. '''Companion animal ingestion:''' * '''1.''' Contact a veterinarian or animal poison control immediately (ASPCA Poison Control: 888-426-4435 in the US). * '''2.''' Note the type of chocolate, cocoa percentage, amount consumed, and the animal's weight. * '''3.''' Do not induce [[effect:vomiting]] unless directed by a veterinarian. * '''4.''' Dark chocolate and baking chocolate are the most dangerous due to higher theobromine content. {{/Emergency}} {{Aftercare}} ===Aftercare & Integration=== Standard cocoa consumption requires no specific [[glossary:aftercare]]. For high-dose ceremonial cacao sessions, some individuals report a mild energy dip 4–8 hours after consumption as theobromine clears. Staying hydrated and eating a balanced meal after the session can smooth this transition. If sleep is disrupted by late consumption, the effect is self-limiting and will resolve as theobromine and caffeine are metabolized — typically within 24 hours. Individuals who notice increased anxiety, heart rate, or [[effect:restlessness]] after cocoa consumption should reduce their serving size and evaluate total daily caffeine intake from all sources. {{/Aftercare}} {{Recovery}} ===Recovery & Support=== Cocoa does not produce a clinically significant [[glossary:dependence]] syndrome in most users. However, those consuming large amounts of dark chocolate daily may develop caffeine dependence, with [[glossary:withdrawal]] symptoms ([[effect:headache]], [[glossary:fatigue]], [[effect:irritability]]) resolving within 5–7 days of cessation{{cite|pubmed=11326548|anchor=08ed0f09}}{{cite|pubmed=3772801|anchor=c1c1d118}}. For those seeking to reduce or eliminate heavy daily chocolate consumption: * '''Taper gradually''' rather than stopping abruptly to minimize caffeine withdrawal headache. Reduce daily intake by roughly 25% every 3–4 days. * '''Substitute lower-caffeine preparations''' — milk chocolate or cocoa powder beverages contain less caffeine than dark chocolate. * '''Track total caffeine intake''' across all sources (coffee, tea, chocolate, medications) to identify the true scope of dependence. If caffeine dependence is causing significant [[glossary:distress]] or functional [[glossary:impairment]], consult a healthcare provider. SAMHSA's National Helpline (1-800-662-4357) provides free, confidential [[glossary:referral|referrals]] 24/7. {{/Recovery}}

===Forms & Identification=== Cocoa products are sold as food commodities and are not subject to the [[glossary:adulterant|adulteration]] risks typical of unregulated psychoactive substances. However, heavy metal [[glossary:contamination]] — particularly cadmium and lead — is a documented concern in dark chocolate and cocoa powder{{cite|doi=10.1021/acs.jafc.9b08295|anchor=c6a7899a}}. Third-party testing programs (e.g., ConsumerLab, As You Sow) periodically publish heavy metal [[glossary:assay]] results for commercial chocolate brands. Consumers concerned about cumulative cadmium exposure — especially those consuming dark chocolate daily or feeding it to children — should seek brands that publish independent Certificates of Analysis or that source beans from regions with lower soil cadmium levels (West Africa generally shows lower cadmium than Latin American origins). For ceremonial cacao preparations sold outside conventional food retail, provenance and processing transparency are less standardized. No regulatory framework requires heavy metal disclosure for these products in most jurisdictions. ===Set & Setting=== Cocoa's psychoactive effects are mild enough that set-and-setting considerations are minimal for standard dietary consumption. For ceremonial cacao sessions — which use substantially higher doses and are often conducted in group ritual contexts — participants should be aware that the elevated methylxanthine load can produce noticeable cardiovascular [[effect:stimulation]] ([[glossary:heart-rate]] increase, flushing, [[glossary:warmth]]). Individuals with [[substance:caffeine]] [[glossary:sensitivity]], [[effect:anxiety]] [[glossary:disorder|disorders]], or cardiovascular conditions should approach high-dose preparations cautiously. {{Guideline}} ===Guidelines=== * '''Start low with new preparations.''' Ceremonial cacao doses (28–42 g paste) deliver significantly more [[substance:theobromine]] and caffeine than a standard cocoa beverage. Begin with half a ceremonial dose if unfamiliar with the preparation. * '''Count dark chocolate toward daily caffeine intake.''' A 100 g serving of 85% dark chocolate contains roughly 40–80 mg caffeine. Individuals monitoring caffeine for sleep, anxiety, or [[glossary:pregnancy]] should track this. * '''Choose tested products for regular consumption.''' When consuming dark chocolate or cocoa powder daily, prefer brands with published third-party heavy metal testing. Rotate sources to reduce single-origin contaminant [[glossary:accumulation]]. * '''Time consumption appropriately.''' Theobromine's 6–10 hour [[glossary:half-life]] means late-afternoon or evening consumption — especially of dark chocolate — can interfere with sleep in caffeine-sensitive individuals. * '''Keep all cocoa and chocolate products away from dogs and cats.''' Theobromine is severely toxic to companion animals at doses easily reached by a single chocolate bar{{cite|pubmed=41030422|anchor=aaac1e28}}. {{/Guideline}} {{Emergency}} ===Emergency Response=== '''Recognizing an emergency in humans:''' Cocoa-related emergencies are exceedingly rare at dietary doses. Red flags include severe [[glossary:chest-pain]], heart palpitations, difficulty breathing, or signs of allergic reaction (swelling, hives, throat tightness) after consumption. '''Immediate steps:''' * '''1.''' Call emergency services (911 / 112 / local equivalent) if the person experiences chest pain, difficulty breathing, or [[glossary:loss-of-consciousness]]. * '''2.''' Keep the person calm, seated, and breathing steadily. * '''3.''' Note what was consumed, how much, and when. '''What to tell the dispatcher:''' Substance consumed (type of chocolate or cacao product), approximate amount, time of consumption, and current symptoms. Mention any [[glossary:medication|medications]] the person takes — particularly [[substance_class:pharmacological/monoamine-oxidase-inhibitor|monoamine oxidase inhibitors]] or cardiac medications. '''Companion animal ingestion:''' * '''1.''' Contact a veterinarian or animal poison control immediately (ASPCA Poison Control: 888-426-4435 in the US). * '''2.''' Note the type of chocolate, cocoa percentage, amount consumed, and the animal's weight. * '''3.''' Do not induce [[effect:vomiting]] unless directed by a veterinarian. * '''4.''' Dark chocolate and baking chocolate are the most dangerous due to higher theobromine content. {{/Emergency}} {{Aftercare}} ===Aftercare & Integration=== Standard cocoa consumption requires no specific [[glossary:aftercare]]. For high-dose ceremonial cacao sessions, some individuals report a mild energy dip 4–8 hours after consumption as theobromine clears. Staying hydrated and eating a balanced meal after the session can smooth this transition. If sleep is disrupted by late consumption, the effect is self-limiting and will resolve as theobromine and caffeine are metabolized — typically within 24 hours. Individuals who notice increased anxiety, heart rate, or [[effect:restlessness]] after cocoa consumption should reduce their serving size and evaluate total daily caffeine intake from all sources. {{/Aftercare}} {{Recovery}} ===Recovery & Support=== Cocoa does not produce a clinically significant [[glossary:dependence]] syndrome in most users. However, individuals who consume large amounts of dark chocolate daily may develop caffeine dependence, with [[glossary:withdrawal]] symptoms ([[effect:headache]], [[glossary:fatigue]], [[effect:irritability]]) resolving within 5–7 days of cessation{{cite|pubmed=11326548|anchor=a597e440}}{{cite|pubmed=3772801|anchor=90976a84}}. For those seeking to reduce or eliminate heavy daily chocolate consumption: * '''Taper gradually''' rather than stopping abruptly to minimize caffeine withdrawal headache. Reduce daily intake by roughly 25% every 3–4 days. * '''Substitute lower-caffeine preparations''' — milk chocolate or cocoa powder beverages contain less caffeine than dark chocolate. * '''Track total caffeine intake''' across all sources (coffee, tea, chocolate, medications) to identify the true scope of dependence. If caffeine dependence is causing significant [[glossary:distress]] or functional [[glossary:impairment]], consult a healthcare provider. SAMHSA's National Helpline (1-800-662-4357) provides free, confidential [[glossary:referral|referrals]] 24/7. {{/Recovery}}

Cocoa, chocolate, and all products derived from ''Theobroma cacao'' are regulated worldwide exclusively as food commodities. Neither the plant nor its constituent alkaloids — [[substance:theobromine]], [[substance:caffeine]], or phenylethylamine — are listed under the United Nations 1961 Single Convention on Narcotic Drugs, the 1971 [[glossary:convention-on-psychotropic-substances]], or the 1988 Convention Against Illicit Traffic in Narcotic Drugs. No jurisdiction classifies cocoa, chocolate, or theobromine as a controlled or scheduled substance. In the United States, cocoa is an [[glossary:fda]]-regulated food with labeling standards under 21 CFR §163; theobromine is not [[glossary:drug-enforcement-administration|DEA]]-scheduled. The European Union regulates cocoa composition under Directive 2000/36/EC and enforces cadmium limits of 0.1–0.3 mg/kg depending on product type. The UK, Canada, and Australia regulate cocoa as food under their respective food safety frameworks. Caffeine is monitored (not prohibited) by the World Anti-Doping Agency in sporting contexts; theobromine is not monitored or prohibited by any sporting authority or [[glossary:drug-control]] regime. {{Warning}} Legal status changes frequently. This overview reflects the status as of the article's last update and is not legal advice. Verify current law in the relevant jurisdiction before acting on this information. {{/Warning}}

===Adenosine receptor antagonism=== [[substance:theobromine]]'s primary [[glossary:central-nervous-system]] action is [[glossary:antagonism]] of [[glossary:adenosine]] A₁ and A₂A [[glossary:receptor|receptors]]. At physiologically relevant concentrations (30 μM), theobromine facilitates synaptic [[glossary:transmission]] via A₁R [[glossary:blockade]] and impairs long-term [[glossary:potentiation]] via A₂AR blockade in [[glossary:hippocampus|hippocampal]] [[glossary:neuron|neurons]]{{cite|doi=10.3390/ijms231810510|anchor=95cac1cf}}. This dual action also confers neuroprotection against amyloid-β₁₋₄₂-induced neuronal loss ''in vitro''{{cite|doi=10.3390/ijms231810510|anchor=ce95b1fa}}. [[substance:caffeine]] shares these receptor targets but is present in cocoa at approximately one-tenth the concentration of theobromine. Both methylxanthines promote sustained cognitive performance and neuronal protection in [[glossary:animal-model|animal models]] of [[glossary:stroke]], Alzheimer's disease, and Parkinson's disease via adenosine receptor antagonism{{cite|doi=10.1007/s11064-018-2492-0|anchor=25d9c382}}. ===Phosphodiesterase inhibition=== Both theobromine and caffeine inhibit phosphodiesterases (PDEs), preventing [[glossary:hydrolysis]] of cAMP and cGMP. The resulting increase in intracellular cAMP activates protein kinase A, with downstream effects on glucose [[glossary:metabolism]], cardiac contractility, and smooth [[effect:muscle-relaxation]]{{cite|doi=10.3389/fphar.2015.00030|anchor=9a82370f}}{{cite|doi=10.3390/molecules21080974|anchor=a5f105c5}}. ===Vascular mechanisms=== Cocoa flavanols — principally epicatechin and its [[glossary:metabolite|metabolites]] — stimulate endothelial nitric oxide synthase (eNOS), increasing nitric oxide production and producing vasodilation{{cite|doi=10.1016/j.vph.2015.05.011|anchor=f8a28fac}}. This mechanism is distinct from and additive to the methylxanthine pathway. Theobromine independently attenuates ADP- and TRAP6-induced platelet aggregation through a flavanol-independent mechanism that remains under investigation{{cite|doi=10.1016/j.vph.2015.02.010|anchor=8cebc282}}. ===Antitussive mechanism=== In a randomized, [[glossary:double-blind]], [[glossary:placebo-controlled-trial]], theobromine suppressed capsaicin-induced cough in humans without [[glossary:adverse-effects]]. The proposed mechanism is peripheral [[glossary:inhibition]] of capsaicin-induced sensory nerve depolarization of the vagus nerve — a pathway distinct from adenosine receptor antagonism{{cite|pubmed=15548587|anchor=2293e326}}. ===Pharmacokinetics=== Theobromine exhibits high oral bioaccessibility (>85% from the cocoa matrix in simulated gastrointestinal digestion){{cite|doi=10.1039/d5fo05193b|anchor=393cb457}}. Its [[glossary:half-life]] in humans is approximately 6–10 hours{{cite|doi=10.3389/fphar.2015.00030|anchor=b7ace82d}}{{flag|safety-citation-needed}}. No primary human pharmacokinetic study specifically characterizing theobromine kinetics was identified in the published literature; this estimate derives from secondary review sources. Caffeine is metabolized primarily by [[glossary:cyp1a2]] to paraxanthine (major metabolite), theobromine, and theophylline{{cite|pubmed=18068204|anchor=e6b287ba}}. Caffeine [[glossary:clearance]] exhibits dose-dependent nonlinear kinetics, decreasing at higher chronic doses and producing disproportionate [[glossary:accumulation]]{{flag|citation-needed}}. Epicatechin from cocoa exhibits biphasic [[glossary:absorption]]: a primary cmax of approximately 260 nmol/L at tmax ~1.8 h (small intestinal absorption) and a secondary peak of ~88 nmol/L at ~5.3 h (colonic microbial metabolites){{cite|doi=10.1016/j.mam.2022.101146|anchor=ad408694}}. Mean [[glossary:bioavailability]] from cocoa is approximately 25%, compared with ~82% from pure epicatechin{{cite|doi=10.1016/j.mam.2022.101146|anchor=03a3e925}}. Theobromine [[glossary:co-ingestion|co-ingestion]] increases epicatechin cmax by 21%, demonstrating a synergistic [[glossary:pharmacokinetic-interaction]] between cocoa constituents{{cite|doi=10.1016/j.freeradbiomed.2023.01.003|anchor=ad260cb7}}. ===Open questions=== No neuroimaging studies (fMRI, PET, EEG) specifically examining the effects of cocoa or chocolate consumption on brain activity during acute dosing have been published. Whether the ''in vitro'' endocannabinoid-mimicking activity of cocoa N-acylethanolamines produces measurable CNS effects at dietary doses remains unestablished. The preparation-specific [[glossary:pharmacokinetics]] of high-dose "ceremonial cacao" preparations have not been characterized.

Cocoa, chocolate, and all products derived from ''Theobroma cacao'' are regulated exclusively as food commodities worldwide. Neither the plant nor its constituent alkaloids — [[substance:theobromine]], [[substance:caffeine]], or phenylethylamine — are listed under the United Nations 1961 Single Convention on Narcotic Drugs, the 1971 [[glossary:convention-on-psychotropic-substances]], or the 1988 Convention Against Illicit Traffic in Narcotic Drugs. No jurisdiction classifies cocoa, chocolate, or theobromine as a controlled, restricted, or scheduled substance.

Jurisdiction	Classification	Key provisions
United States (federal)	Food commodity (FDA regulated)	Standard of identity requirements for chocolate labeling (21 CFR §163). Theobromine is not DEA-scheduled.
European Union	Food commodity	Directive 2000/36/EC: "Chocolate" requires ≥35% total dry cocoa solids; "Milk Chocolate" requires ≥25%. Cadmium limits apply (Regulation EC No 488/2014, updated 2019): 0.1–0.3 mg/kg depending on product type.
European Union (supply chain)	Supply chain regulation	EU Deforestation Regulation (effective December 2024): cocoa products must demonstrate production on land not deforested or degraded after December 2020.
United Kingdom	Food commodity	Not scheduled under Misuse of Drugs Act 1971. Regulated as food under retained EU food law and Food Standards Agency oversight.
Canada	Food commodity	Not scheduled. Regulated under Food and Drugs Act and CFIA standards for chocolate products.
Australia	Food commodity	Not scheduled under Poisons Standard (SUSMP). Regulated under FSANZ Food Standards Code.
International (Codex)	Voluntary food standard	Codex Alimentarius CODEX STAN 87-1981 establishes international compositional standards for chocolate and cocoa products.

Caffeine is monitored (not prohibited) by the World Anti-Doping Agency (WADA) in sporting contexts. Theobromine is not monitored or prohibited by any sporting authority or [[glossary:drug-control]] regime.

Cocoa's subjective effect profile is notably subtle relative to other [[substance_class:psychoactive/stimulant]] preparations and is characterized primarily by mild [[effect:wakefulness]], gentle mood [[glossary:elevation]], and a diffuse sense of physical [[glossary:warmth]]. The experiential character varies between preparations: cocoa powder beverages produce a gradual, even [[effect:stimulation]], while dark chocolate delivers a more concentrated methylxanthine load alongside food matrix effects — satiety, orosensory [[glossary:pleasure]] — that may confound purely pharmacological attribution. [[glossary:set-and-setting]] exert relatively modest influence on cocoa's effects compared to stronger psychoactive substances; preparation type and dose are the primary experiential modifiers. Cocoa occupies the lowest [[glossary:intensity]] position among commonly consumed methylxanthine preparations. Its stimulant character is substantially milder than that of coffee, consistent with [[substance:theobromine]]'s weaker [[glossary:brain-penetration|CNS penetration]] and approximately tenfold lower [[substance:caffeine]] content per typical serving. The overall experiential profile more closely resembles a mild green tea than a strong coffee, with a longer, more diffuse duration curve reflecting theobromine's 6–10 hour [[glossary:half-life]].

===Toxicity=== [[substance:theobromine]] is considered safe at typical human dietary exposures. In comparative acute oral [[glossary:toxicity]] studies following OECD guidelines, theobromine at 2,000 mg/kg produced 66.6% [[glossary:mortality]] in mice and 33.3% mortality in rats{{cite|doi=10.1080/01480545.2019.1635615|anchor=b4d02136}}{{flag|additional-citations-needed}}. No primary published study establishing a human [[glossary:lethal-dose|LD50]] for theobromine was identified in the literature; [[glossary:secondary-source|secondary sources]] estimate approximately 1,000 mg/kg, but this value could not be independently verified{{flag|safety-citation-needed}}. In teratogenicity studies, theobromine exposure at 200 mg/kg/day by gavage approached the maternal LD50 in New Zealand White rabbits. At 125–200 mg/kg/day, fetal weight decreases and skeletal malformations were observed, while dietary exposure at ≤63 mg/kg/day — approximately 38 times the estimated maximum [[glossary:human-consumption]] — showed no fetotoxicity or teratogenicity{{cite|pubmed=3744189|anchor=f6f65ea5}}{{flag|additional-citations-needed}}. No published [[glossary:case-report|case reports]] of human hospitalization or [[glossary:fatality]] from dietary cocoa or chocolate consumption at normal intake levels were identified. Theobromine is severely toxic to dogs and cats due to markedly slower N-demethylation capacity; a case of chocolate [[glossary:ingestion]] in a Corgi (88.3 mg/kg body weight) produced severe [[glossary:tachycardia]], [[glossary:tremor|tremors]], [[glossary:seizure|seizures]], and prolonged neurological [[glossary:sequela|sequelae]]{{cite|pubmed=41030422|anchor=1ae0ed51}}{{flag|additional-citations-needed}}. ====Contaminant and adulterant risk==== '''Cadmium''' is the most significant [[glossary:contamination|contaminant]] concern for commercial cocoa products. Cacao plants bioaccumulate cadmium from soil, with Latin American production regions (Peru, Ecuador, Colombia, Bolivia) exhibiting naturally elevated soil cadmium levels{{cite|doi=10.1021/acs.jafc.9b08295|anchor=702b5172}}{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=617b1928}}. Cadmium has a biological [[glossary:half-life]] of 10–30 years and accumulates in renal tissue, posing heightened risk to children — the primary consumers of chocolate products{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=5aed87a7}}{{cite|doi=10.1016/j.fct.2025.115799|anchor=924ab223}}. The European Union enforces cadmium limits of 0.3 mg/kg for cocoa powder and 0.1 mg/kg for milk chocolate. Dark chocolate contains higher cadmium concentrations than milk or white chocolate due to higher cocoa solids content{{cite|doi=10.1016/j.fct.2025.115799|anchor=a3efedf9}}. Disproportionate health risk has been noted for Black and Hispanic children due to compounding environmental lead exposures{{cite|doi=10.1016/j.fct.2025.115799|anchor=6244c0af}}. '''Lead''' has been documented at measurable levels in dark chocolate, with some samples exceeding international limits. Contamination is largely post-harvest, from environmental deposition during open-air drying{{cite|doi=10.1021/acs.jafc.9b08295|anchor=e7a6561e}}{{flag|additional-citations-needed}}. '''Arsenic''' has been detected in cocoa powder at a mean concentration of 0.06 mg/kg{{flag|citation-needed}}. No published data on pesticide residues or mycotoxin contamination in commercial cocoa products were identified in the retrieved literature{{flag|safety-citation-needed}}. No standardized consumer-facing heavy metal disclosure regime exists for cocoa products in most jurisdictions; cadmium content is not routinely reported on product labels. ===Psychological risks=== At typical dietary doses, cocoa presents minimal acute [[glossary:psychological-risk]]. High [[substance:caffeine]] intake — achievable through heavy dark chocolate consumption — can produce dose-dependent [[effect:anxiety]], [[effect:insomnia]], and tremor, with individual variation modulated by [[glossary:cyp1a2]] [[glossary:genetic-polymorphism|polymorphisms]] and [[glossary:adenosine]] [[glossary:receptor]] [[glossary:sensitivity]]{{cite|doi=10.3389/fphar.2015.00030|anchor=8aeca582}}{{flag|additional-citations-needed}}. No [[glossary:psychotomimetic|psychotomimetic effects]] have been documented at dietary doses. The endocannabinoid-mimic [[glossary:hypothesis]] — that cocoa N-acylethanolamines produce [[substance:cannabis]]-like [[index:effects|subjective effects]] — has not been confirmed in human behavioral studies{{cite|pubmed=8751435|anchor=a86a4081}}{{cite|pubmed=10876983|anchor=d284c941}}{{cite|pubmed=11363932|anchor=52edb222}}. Chocolate [[effect:craving]] is documented as a behavioral phenomenon in the published literature, but whether it reflects pharmacological [[glossary:reinforcement]] (methylxanthine effects), nutritional need, or conditioned learned response remains contested{{flag|citation-needed}}. ===Tolerance and dependence=== ====Tolerance==== [[glossary:tolerance]] to the subjective and sleep-disrupting effects of caffeine develops with repeated use at habitual doses{{cite|pubmed=11326548|anchor=e4d1e21e}}{{flag|additional-citations-needed}}. Tolerance may therefore develop to cocoa's [[substance_class:psychoactive/stimulant]] effects at heavy habitual consumption levels. No tolerance phenomenon specific to theobromine has been documented. ====Dependence==== Caffeine [[glossary:physical-dependence]] is well established for caffeine-containing preparations generally. [[glossary:withdrawal]] symptoms begin 12–24 hours after last dose, peak at days 1–2, and resolve within 5–7 days. The primary symptoms are [[effect:headache]] (most common), [[glossary:fatigue]], [[effect:irritability]], decreased alertness, and flu-like symptoms{{cite|pubmed=11326548|anchor=ec0abef5}}{{cite|pubmed=3772801|anchor=5703abc3}}. DSM-IV caffeine [[glossary:dependence]] criteria are met in 9–30% of heavy caffeine users{{cite|pubmed=11326548|anchor=91c6552e}}. The minimum daily dose to produce caffeine dependence is as low as 100 mg/day{{cite|pubmed=11326548|anchor=e255fcd6}}. Whether cocoa-specific consumption produces a clinically meaningful dependence syndrome has not been studied. The caffeine content of a typical dark chocolate serving (approximately 40–80 mg per 100 g) is below that of a standard coffee serving (~95 mg) but approaches the threshold for dependence with daily heavy consumption. No dependence syndrome or withdrawal phenomenon specific to theobromine has been documented; theobromine has fewer [[glossary:central-nervous-system|CNS]] effects and lower reinforcing potential than caffeine{{cite|doi=10.3389/fphar.2015.00030|anchor=d11c23ea}}{{flag|additional-citations-needed}}. ===Drug interactions=== No published case reports of clinically significant herb–[[glossary:drug-interaction|drug interactions]] specifically from dietary cocoa consumption were identified in the literature. The following interactions are pharmacologically plausible but lack clinical case report confirmation. '''MAO inhibitor interaction:''' Irreversible [[substance_class:pharmacological/monoamine-oxidase-inhibitor|monoamine oxidase inhibitors]] (phenelzine, tranylcypromine) reduce [[glossary:first-pass-metabolism]] of dietary tyramine and phenylethylamine. Chocolate contains trace amounts of both biogenic amines from fermentation. This could theoretically precipitate a hypertensive crisis, though no published case report specifically implicating cocoa or chocolate has been identified{{flag|safety-citation-needed}}. '''Adenosine antagonism:''' Caffeine and theobromine pharmacodynamically oppose the effects of therapeutic adenosine (used in cardiac stress testing and supraventricular tachycardia management). High cocoa intake before adenosine-based cardiac procedures could attenuate drug [[glossary:efficacy]]{{flag|safety-citation-needed}}. '''CYP-mediated interactions:''' Epicatechin [[glossary:metabolite|metabolites]] may modulate [[glossary:cyp3a4]] and P-glycoprotein activity ''in vitro''{{cite|doi=10.1016/j.mam.2022.101146|anchor=aee81053}}. Clinical significance at dietary cocoa doses has not been established. Caffeine is metabolized by CYP1A2; drugs that inhibit or induce CYP1A2 (fluvoxamine, ciprofloxacin, smoking) will alter caffeine and theobromine [[glossary:clearance]] from cocoa consumption{{cite|pubmed=18068204|anchor=76dd4970}}. {{Info}}All interaction [[glossary:severity]] assessments for cocoa remain unrated due to the absence of clinical case reports or primary [[glossary:pharmacokinetic-interaction]] studies specific to dietary cocoa products.{{/Info}} ===Contraindications=== '''Pregnancy:''' Caffeine exposure during [[glossary:pregnancy]] is associated with dose-dependent adverse outcomes. A meta-analysis of 60 studies found that each 100 mg increment in daily caffeine intake was associated with a 14% increase in spontaneous abortion risk, a 19% increase in stillbirth risk, and a 10% increase in small-for-gestational-age birth risk{{cite|doi=10.1007/s10654-014-9944-x|anchor=af98caf0}}{{flag|additional-citations-needed}}. UK NHS and WHO guidelines recommend ≤200 mg caffeine/day during pregnancy. Heavy dark chocolate consumption (200–300 g daily of 70%+ cocoa chocolate) could contribute 80–240 mg caffeine toward this limit; pregnant individuals should count dark chocolate toward total daily caffeine intake. '''Pediatric populations:''' Cadmium bioaccumulation risk is heightened in children due to lower body mass and longer remaining exposure horizons. Dark chocolate is not recommended as a primary food for young children on the basis of heavy metal content{{cite|doi=10.1016/j.fct.2025.115799|anchor=78886104}}{{cite|doi=10.1016/j.scitotenv.2020.137645|anchor=e06708dc}}. '''Companion animals:''' Theobromine is severely toxic to dogs and cats due to their limited N-demethylation capacity. Any cocoa or chocolate ingestion by companion animals warrants immediate veterinary evaluation{{cite|pubmed=41030422|anchor=eba43921}}{{flag|additional-citations-needed}}. '''Hepatic impairment:''' CYP1A2 is hepatically expressed. Impaired liver function will reduce caffeine and theobromine clearance, prolonging stimulant effects and increasing [[glossary:accumulation]] risk. No cocoa-specific hepatic safety data have been published{{flag|safety-citation-needed}}. '''MAO inhibitor use:''' Patients taking irreversible monoamine oxidase inhibitors should be counseled regarding potential tyramine and phenylethylamine content in chocolate, though the clinical significance of this interaction remains unconfirmed for cocoa-specific consumption.

Cocoa, chocolate, and all products derived from ''Theobroma cacao'' are regulated exclusively as food commodities worldwide. Neither the plant nor its constituent alkaloids — [[substance:theobromine]], [[substance:caffeine]], or phenylethylamine — are listed in the United Nations 1961 Single Convention on Narcotic Drugs, the 1971 [[glossary:convention-on-psychotropic-substances]], or the 1988 Convention Against Illicit Traffic in Narcotic Drugs.

Jurisdiction	Classification	Key provisions
United States (federal)	Food commodity (FDA regulated)	Standard of identity requirements for chocolate labeling (21 CFR §163). No DEA scheduling of theobromine or cocoa products.
European Union	Food commodity	Directive 2000/36/EC harmonizes composition requirements: "Chocolate" requires ≥35% total dry cocoa solids; "Milk Chocolate" requires ≥25% cocoa solids. EU cadmium limits apply (Regulation EC No 488/2014, updated 2019): 0.1–0.3 mg/kg depending on product type.
European Union (deforestation)	Supply chain regulation	EU Deforestation Regulation (effective December 2024): cocoa products sold in or exported from the EU must demonstrate production on land not deforested or degraded after December 2020.
United Kingdom	Food commodity	No scheduling under Misuse of Drugs Act 1971. Regulated as food under retained EU food law and Food Standards Agency oversight.
Canada	Food commodity	No scheduling. Regulated under Food and Drugs Act and CFIA standards for chocolate products.
Australia	Food commodity	No scheduling under Poisons Standard (SUSMP). Regulated as food under Food Standards Australia New Zealand (FSANZ) Code.
International (Codex)	Voluntary food standard	Codex Alimentarius CODEX STAN 87-1981 establishes international compositional standards for chocolate and cocoa products.

Caffeine is monitored (not prohibited) by the World Anti-Doping Agency (WADA) in sporting contexts. Theobromine is not monitored or prohibited by any sporting authority or [[glossary:drug-control]] regime. No jurisdiction classifies cocoa, chocolate, theobromine, or cocoa-derived preparations as controlled, restricted, or scheduled substances.